Search

Author/Creator Cluzeau, T.

2. 50 BCL2L10-POSITIVE CELL (BPC) QUANTIFICATION IS A PREDICTIVE FACTOR OF SURVIVAL IN AZA-TREATED HIGHER RISK MDS (HR-MDS) AND AML. (April 2015)

Authors:
Cluzeau, T.; Vidal, V.; Ginet, C.; Karsenti, J.M.; Luciano, F.; Gastaud, L.; Garnier, G.; Braun, T.; Hirsch, P.; Raffoux, E.; Nloga, A.M.; Dombret, H.; Rorhlich, P.; Ades, L.; Chomienne, C.; Auberger, P.; Robert, G.; Fenaux, P.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021)

Authors:
Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; Lucas, N.; Vidal, V.; Salanoubat, C.; Michel, J.; Mediavilla, C.; Ojeda-Uribe, M.; Alexis, M.; Frayfer, J.
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 7(2021)
Page Start:
1756
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Evaluation of Salvage Induction Chemotherapy Regimens in Myelodysplastic Syndrome and Acute Myeloid Leukemia after Hypomethylating Agent Treatment Failure. (April 2017)

Authors:
Ball, B.; Komrokji, R.; Adès, L.; Sekeres, M.; DeZern, A.; Pleyer, L.; Vey, N.; Almeida, A.; Germing, U.; Cluzeau, T.; Platzbecker, U.; Gore, S.; Fenaux, P.; Prebet, T.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S58
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (1st March 2022)

Authors:
Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y.
Journal:
British journal of dermatology
Issue:
Volume 186:Number 3(2022)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients. (28th November 2021)

Authors:
Georgin‐Lavialle, S.; Terrier, B.; Guedon, A.F.; Heiblig, M.; Comont, T.; Lazaro, E.; Lacombe, V.; Terriou, L.; Ardois, S.; Bouaziz, J.‐D.; Mathian, A.; Le Guenno, G.; Aouba, A.; Outh, R.; Meyer, A.; Roux‐Sauvat, M.; Ebbo, M.; Zhao, L.P.; Bigot, A.; Jamilloux, Y.
Journal:
British journal of dermatology
Issue:
Volume 186:Number 3(2022)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYELOID CLINICAL TRIAL PROGRAM. (23rd June 2022)

Authors:
Zeidan, A. M.; Al-Kali, A.; Borate, U.; Cluzeau, T.; DeZern, A. E.; Esteve, J.; Giagounidis, A.; Kobata, K.; Lyons, R.; Platzbecker, U.; Sallman, D. A.; Santini, V.; Sanz, G. F.; Sekeres, M. A.; Wei, A. H.; Xiao, Z.; Van Hoef, M.; Nourry-Boulot, C.; Sadek, I.; Ma, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗